Far Infrared Irradiation for the Management, Control and Treatment of Frontotemporal Dementia
Primary Purpose
Pick Disease of the Brain
Status
Unknown status
Phase
Phase 1
Locations
Canada
Study Type
Interventional
Intervention
Radiation: Far Infrared Radiation (5μm to 20μm wavelength)
Sponsored by
About this trial
This is an interventional treatment trial for Pick Disease of the Brain focused on measuring Brain Atrophy, Circumscribed Lobar, Circumscribed Lobar Atrophy of the Brain, Lobar Atrophy (Brain), Pick Disease, Pick's Disease, Picks Disease of Brain
Eligibility Criteria
Inclusion Criteria:
- People with Pick's Disease
Exclusion Criteria:
- None
Sites / Locations
- The Centre for Incurable Diseases
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
1
Arm Description
Radiation: Far Infrared Radiation (5μm to 20μm wavelength)
Outcomes
Primary Outcome Measures
Therapy for FTD patients
Secondary Outcome Measures
Rehabilitation of FTD Patients
Full Information
NCT ID
NCT00674960
First Posted
May 6, 2008
Last Updated
August 14, 2009
Sponsor
GAAD Medical Research Institute Inc.
1. Study Identification
Unique Protocol Identification Number
NCT00674960
Brief Title
Far Infrared Irradiation for the Management, Control and Treatment of Frontotemporal Dementia
Official Title
Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation for the Management, Control and Treatment of Frontotemporal Dementia (Pick's Disease)
Study Type
Interventional
2. Study Status
Record Verification Date
August 2009
Overall Recruitment Status
Unknown status
Study Start Date
May 2008 (undefined)
Primary Completion Date
May 2009 (Anticipated)
Study Completion Date
October 2009 (Anticipated)
3. Sponsor/Collaborators
Name of the Sponsor
GAAD Medical Research Institute Inc.
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Pick's disease, also known as Pick disease,or FTD is a rare fronto-temporal neurodegenerative disease. This study will investigate the use of far infrared radiation for the control, management and treatment of Pick's disease.
Detailed Description
This disorder causes progressive destruction of nerve cells in the brain and causes tau proteins to accumulate into the "Pick bodies" that are a defining characteristic of the disease. Tau proteins are microtubule-associated proteins that are abundant in neurons in the central nervous system and are less common elsewhere.
Observations from our research studies indicate that, far infrared rays provide energy to the body, improve the autonomic functions of the nervous system, restore the functions of the endocrine system, strengthen the immune system, improve blood circulation and increase the level of oxygen in the cells and promote the regeneration of muscle cells, nerves and brain cells.
It is hereby postulated that irradiation using far infrared, with wavelength between 5 to 20 microns, of the central nervous system, the endocrine system and the whole body could prevent, control, manage or possibly lead to complete rehabilitation of people who have FTD.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pick Disease of the Brain
Keywords
Brain Atrophy, Circumscribed Lobar, Circumscribed Lobar Atrophy of the Brain, Lobar Atrophy (Brain), Pick Disease, Pick's Disease, Picks Disease of Brain
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 1
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
1
Arm Type
Experimental
Arm Description
Radiation: Far Infrared Radiation (5μm to 20μm wavelength)
Intervention Type
Radiation
Intervention Name(s)
Radiation: Far Infrared Radiation (5μm to 20μm wavelength)
Other Intervention Name(s)
Far Infrared Radiation (5μm to 20μm wavelength)
Intervention Description
Far Infrared Radiation (5μm to 20μm wavelength). Far Infrared radiation for 30 to 40 minutes per treatment session.
Primary Outcome Measure Information:
Title
Therapy for FTD patients
Time Frame
1 year
Secondary Outcome Measure Information:
Title
Rehabilitation of FTD Patients
Time Frame
1 Year
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
People with Pick's Disease
Exclusion Criteria:
None
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ken Nedd, M.D.
Organizational Affiliation
GAAD Medical Research Institute Inc.
Official's Role
Principal Investigator
Facility Information:
Facility Name
The Centre for Incurable Diseases
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M4V 1L5
Country
Canada
12. IPD Sharing Statement
Learn more about this trial
Far Infrared Irradiation for the Management, Control and Treatment of Frontotemporal Dementia
We'll reach out to this number within 24 hrs